Skip to content
Menu

Oppenheimer Initiates Coverage On PolyPid with Outperform Rating, Announces Price Target of $10

Benzinga Newsdesk 3 weeks ago

Analyst RatingsNewsInitiationPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Oppenheimer analyst Les Sulewski initiates coverage on PolyPid (NASDAQ:PYPD) with a Outperform rating and announces Price Target of $10.

Oppenheimer analyst Les Sulewski initiates coverage on PolyPid (NASDAQ:PYPD) with a Outperform rating and announces Price Target of $10.

Read at benzinga.com